Related Experiment Video
Updated: Jun 13, 2026
07:42
Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics
David Wald1, Johanna M Vermaat, Gil Peleg
1Department of Medicine, Division of Hematology/Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
Current Hematologic Malignancy Reports
|April 29, 2010
Summary
Acute myelogenous leukemia (AML) classification relies on cytogenetics. Molecular markers may refine risk stratification for intermediate-risk patients lacking these abnormalities, guiding personalized treatment strategies.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute myelogenous leukemia (AML) is characterized by blocked hematopoietic progenitor cell differentiation and uncontrolled proliferation.
- Cytogenetic abnormalities at diagnosis are crucial for classifying AML patients into favorable, intermediate, and poor-risk groups.
- Current treatment strategies for AML are risk-stratified, but optimal approaches for intermediate-risk patients without cytogenetic abnormalities (NC AML) remain unclear.
Purpose of the Study:
- To investigate the role of molecular markers in refining risk stratification for intermediate-risk AML patients.
- To explore potential therapeutic implications of identifying poor-risk subgroups within the NC AML population.
Main Methods:
- Analysis of mutations in NPM1, FLT3, MLL, and CEBPalpha.
- Assessment of expression levels of BAALC, MN1, and ERG.
- Correlation of molecular findings with clinical outcomes in NC AML patients.
Main Results:
- Emerging data suggest specific molecular alterations can identify poor-risk patients within the NC AML group.
- These molecular markers may have prognostic value beyond traditional cytogenetic analysis.
Conclusions:
- Molecular profiling holds promise for improved risk stratification in NC AML.
- Further prospective studies are needed to validate these findings and guide more aggressive therapies for identified poor-risk NC AML patients.
More Related Videos
Related Concept Videos
01:17Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
01:17Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...